Ads
related to: pfizer, drugs industry
Search results
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoThe biotech group ranks No. 40 out of 197 industry groups that IBD tracks. Meanwhile, the pharma...
Paxlovid Fails to Quell Long Covid Symptoms in Stanford Study
Bloomberg· 1 day agoA 15-day course of Pfizer Inc.’s antiviral Paxlovid didn’t provide significant relief for long Covid...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoSo, MRNA stock ranks narrowly inside the top half of all stocks, regardless the industry group, on...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 3 days agoPfizer: A robust yield at a bargain-basement price For those who are steadfast long...the next 10 to 20 years. Pfizer is a leading player in the global...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Colorado Springs Gazette· 1 day agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew of biosimilars, which are close but not exact copies of branded biologic ...
Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview
The Wall Street Journal· 1 day agoMerck—known as EMD Group in the U.S.— is betting on artificial-intelligence partnerships to develop...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 1 day agoShares continued to climb, hitting a recent intraday high at 23.86 on June 6. Shares now have a top...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 1 day agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 2 days agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Halozyme (HALO) Raises 2024 Financial Guidance, Stock Up 13%
Zacks via Yahoo Finance· 1 day agoHalozyme (HALO) gains 13% as it raises its full-year 2024 financial guidance and updates its...